Comparison of Two Corticosteroid Pre-Infusion Regimens for Pegloticase in the United States: A Retrospective Analysis in Community Rheumatology Practices

BACKGROUND: Pegloticase is a recombinant porcine-like uricase enzyme that is FDA-approved for the treatment of chronic refractory gout in adults. Some patients receiving pegloticase develop anti-drug antibodies, which leads to both loss of pegloticase efficacy and an increased risk for infusion reac...

Descripción completa

Detalles Bibliográficos
Autores principales: Majjhoo, Amar, Kumar, Ada, Zdanis, Michael, LaMoreaux, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879681/
https://www.ncbi.nlm.nih.gov/pubmed/31673974
http://dx.doi.org/10.1007/s40801-019-00164-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879681/
https://www.ncbi.nlm.nih.gov/pubmed/31673974
http://dx.doi.org/10.1007/s40801-019-00164-9

Ejemplares similares